About
Dr. Claudia Jochheim is a Biochemist with more than 20 years of experience in the biotechnology industry. Prior to joining Blaze Bioscience, she was an independent consultant. She formerly held strategic leadership positions as Senior Director/Director of Analytical Biochemistry and Formulations at Seattle Genetics, where she built and led groups of up to 30 scientists. At Seattle Genetics, Dr. Jochheim played a key role in moving the antibody-drug-conjugate Adcetris® from development to the market. Prior to Seattle Genetics, she was Director of Analytical Biochemistry at Corixa and a Senior Scientist/Scientist at Immunex and Amgen, where she was project leader for several development projects, including Enbrel® and Vectibix®. Her experience includes all aspects of technology transfer to contract manufacturing organizations and preparation of product-related CMC regulatory filings with FDA. Dr. Jochheim received her PhD in Analytical Chemistry from the University of Dortmund, G
Position in the VCSift Database
- • 4 investors at Blaze Bioscience are tracked.
- • 14 investors hold the EVP of Process Development & Manufacturing role in VCSift. Claudia Jochheim is one of them.
- • 164 investors are based in Washington, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Washington, US
Contact Information
Find more investors like Claudia
Search Investors